Author Archive

ACXIT Capital Partners AG act as Fairness Opinion Provider to Lotto24’s Supervisory Board and Executive Board in the context of the voluntary public offer of ZEAL Network for all outstanding shares of Lotto24

Zurich, 07 March 2019. On 19 November 2018, ZEAL Network SE (“ZEAL”), a company listed on the Prime Standard sub-segment of the regulated market of the Frankfurt Stock Exchange (“FSE”), with a market capitalization of EUR 197.0m as of 11 February 2019, launched a voluntary public takeover offer (“Public Offer” or the “Transaction”) according to section 10 section 1 sentence 1 of the German Securities Acquisition and Takeover Act for all outstanding shares of Lotto24 AG (“Lotto24” or “the Company”), also listed on the FSE, with a market capitalization of EUR 322.2m as of 11 February 2019.

Continue Reading


Frankfurt, 03 January 2019. Flensburg/ Germany headquartered Netzkontor Gruppe GmbH, a company in the portfolio of S-DAX listed Deutsche Beteiligungs AG (DBAG) and of Private Equity Fund DBAG ECF – which is being advised by DBAG – acquires Leipzig/ Germany based BFE Nachrichtentechnik GmbH, a telecommunication services company active in planning, installation and interference suppression of communication and data networks of all kinds.

Continue Reading

ACXIT Capital Partners advises medpex on the trade sale of its e-commerce activities to Zur Rose Group

  • Link between mail-order activities of medpex and Zur Rose subsidiary DocMorris
  • Additional growth opportunities due to outstandingly complementary activities
  • The founders and managers of medpex will continue to lead the activities and will become shareholders in the Zur Rose Group AG

Frankfurt, 18 October 2018. medpex, the third biggest online pharmacy in Germany, is bundling its activities with Swiss company Zur Rose Group AG. With this step, medpex is setting the basis to continue its successful growth trajectory at a high pace in the future and play a proactive role in market consolidation. The outstandingly complementary activities of medpex and Zur Rose subsidiary DocMorris create additional growth opportunities for both companies. Customers will benefit from an even broader product range and from additional services. The founders and managers of medpex will also become shareholders in Zur Rose Group AG as part of the transaction.

Continue Reading


Frankfurt, 04 October 2018. ACXIT Capital Partners, one of the leading corporate finance and investment advisory firms in Europe, is pleased to announce the addition of senior industry advisor Michael Brecht to its newly established next-gen mobility practice. He is one of the bespoken industry experts in next generation mobility topics with special focus on smart mobility, e-mobility, startup financing and strategic growth.

Continue Reading